Acquiring Company
Medtronic plc
Acquired Company
SPR Therapeutics
Description
Medtronic plc announced its intent to acquire SPR Therapeutics, Inc. for approximately $650 million. This acquisition aims to enhance Medtronic's Neuromodulation portfolio with temporary peripheral nerve stimulation technology. The deal will enable earlier intervention for patients suffering from chronic pain. The transaction is subject to customary closing conditions and regulatory approvals.
Who to call at Medtronic plc, and when
When Medtronic plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Medtronic plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Medtronic plc, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medtronic plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired SPR Therapeutics?
SPR Therapeutics was acquired by Medtronic plc, based in Minneapolis. The deal was reported on May 20, 2026. Medtronic plc is the leading global healthcare technology company headquartered in Dublin, Ireland. Medtronic plc is publicly traded (MDT) and operates in Manufacturing.
When did Medtronic plc acquire SPR Therapeutics?
Medtronic plc's acquisition of SPR Therapeutics was reported on May 20, 2026. Medtronic plc announced its intent to acquire SPR Therapeutics, Inc. for approximately $650 million. This acquisition aims to enhance Medtronic's Neuromodulation portfolio with temporary peripheral nerve stimulation technology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SPR Therapeutics do?
SPR Therapeutics is a Cleveland, OH-based private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain. It is privately held, operating in Biotechnology, and is based in Cleveland.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.